HealthEquity Reports Second Quarter Ended July 31, 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY) Following Beat and Raise
September 7, 2022 8:22 AM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $80.00 price target on HealthEquity, Inc (NASDAQ: HQY) following Q2 beat and raise.
The analyst commented, "2Q beat & raise was driven by ongoing momentum in HSA acct/asset growth and higher HSA yield -owing... More
HealthEquity (HQY) Reports In-Line Q2 EPS
September 6, 2022 4:02 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $206.1 million versus the consensus estimate of $203.82 million.
GUIDANCE:
HealthEquity sees FY2022 EPS of $1.23-$1.32, versus the consensus of $1.28. HealthEquity sees... More
